Go Back
Published January 16, 2026

RLS is proud to have delivered the first U.S. doses for Telix’s BiPASS™️ Phase 3 trial. This milestone highlights the essential role our radiopharmacies play in advancing clinical research and next-generation prostate cancer diagnostics.

https://lnkd.in/e7hvBdzZ

Thank you to our Temple, TX radiopharmacy team for their precision and professionalism.

Together, we’re demonstrating what’s possible when precision meets purpose.

For more information about RLS Radiopharmacies and our commitment to quality, visit us at www.rls.bio.
________________________
RLS RADIOPHARMACIES
Nationally Accredited.
Quality. Reliability. Flexibility.
www.rls.bio

#rls
#rlsradiopharmacies
#TheRLSDifference
#radiopharmaceuticals
#OneTelix